HEADER OXYGEN TRANSPORT 24-MAY-07 2V1F TITLE CRYSTAL STRUCTURE OF RADIATION-INDUCED MYOGLOBIN COMPOUND II - TITLE 2 INTERMEDIATE H AT PH 8.7 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYOGLOBIN; COMPND 3 CHAIN: A; COMPND 4 OTHER_DETAILS: FE(IV)-OH SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: EQUUS CABALLUS; SOURCE 3 ORGANISM_COMMON: HORSE; SOURCE 4 ORGANISM_TAXID: 9796; SOURCE 5 ORGAN: HEART KEYWDS MUSCLE PROTEIN, OXYGEN TRANSPORT, OXYGEN ACTIVATION, PEROXIDASE, KEYWDS 2 MONOOXYGENASE, METAL-BINDING, REACTION INTERMEDIATE, HEME, FERRYL, KEYWDS 3 TRANSPORT, HAEM, IRON, RADIATION EXPDTA X-RAY DIFFRACTION AUTHOR H.-P.HERSLETH,C.H.GORBITZ,K.K.ANDERSSON REVDAT 5 13-DEC-23 2V1F 1 REMARK LINK REVDAT 4 29-SEP-09 2V1F 1 REMARK HET HETNAM HETSYN REVDAT 4 2 1 FORMUL LINK SITE HETATM REVDAT 4 3 1 ANISOU REVDAT 3 24-FEB-09 2V1F 1 VERSN REVDAT 2 29-JAN-08 2V1F 1 JRNL REVDAT 1 12-JUN-07 2V1F 0 JRNL AUTH H.-P.HERSLETH,T.UCHIDA,A.K.ROHR,T.TESCHNER,V.SCHUNEMANN, JRNL AUTH 2 T.KITAGAWA,A.X.TRAUTWEIN,C.H.GORBITZ,K.K.ANDERSSON JRNL TITL CRYSTALLOGRAPHIC AND SPECTROSCOPIC STUDIES OF JRNL TITL 2 PEROXIDE-DERIVED MYOGLOBIN COMPOUND II AND OCCURRENCE OF JRNL TITL 3 PROTONATED FE(IV)-O JRNL REF J.BIOL.CHEM. V. 282 23372 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17565988 JRNL DOI 10.1074/JBC.M701948200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.HERSLETH,B.DALHUS,C.H.GORBITZ,K.K.ANDERSSON REMARK 1 TITL AN IRON HYDROXIDE MOIETY IN THE 1.35 A RESOLUTION STRUCTURE REMARK 1 TITL 2 OF HYDROGEN PEROXIDE DERIVED MYOGLOBIN COMPOUND II AT PH REMARK 1 TITL 3 5.2. REMARK 1 REF J.BIOL.INORG.CHEM. V. 7 299 2002 REMARK 1 REFN ISSN 0949-8257 REMARK 1 PMID 11935353 REMARK 1 DOI 10.1007/S007750100296 REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 36234 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.135 REMARK 3 R VALUE (WORKING SET) : 0.134 REMARK 3 FREE R VALUE : 0.163 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1915 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 REFLECTION IN BIN (WORKING SET) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE SET COUNT : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1199 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 214 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.44000 REMARK 3 B22 (A**2) : -0.03000 REMARK 3 B33 (A**2) : 0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.044 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.042 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.029 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.464 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.981 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.973 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1429 ; 0.051 ; 0.049 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1915 ; 0.950 ; 2.026 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 181 ; 4.168 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 55 ;35.761 ;25.273 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 266 ;11.092 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 2 ;20.271 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 200 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1029 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 788 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 955 ; 0.318 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 174 ; 0.173 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 87 ; 0.215 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 47 ; 0.153 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 822 ; 1.306 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1305 ; 1.929 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 649 ; 2.966 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 598 ; 4.196 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2V1F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1290032656. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 110.0 REMARK 200 PH : 8.70 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8727 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38266 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.180 REMARK 200 RESOLUTION RANGE LOW (A) : 34.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 2.550 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.32 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.140 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1GJN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 32.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BATCH METHOD: 6-12 MG/ML MYOGLOBIN, 80 REMARK 280 -85% OF THE CRYSTALLIZATION STOCK-SOLUTION (3.9 M AMMONIUM REMARK 280 SULPHATE, 0.1 M TAPS AND 5-10% OF GLYCEROL PH 8.7), PH 8.70 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 14.33400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 59 O HOH A 2095 1.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 20 72.94 -153.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A1154 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 93 NE2 REMARK 620 2 HEM A1154 NA 90.0 REMARK 620 3 HEM A1154 NB 89.6 89.4 REMARK 620 4 HEM A1154 NC 91.3 177.8 88.9 REMARK 620 5 HEM A1154 ND 90.7 89.0 178.3 92.7 REMARK 620 6 OH A1155 O 178.1 91.8 89.9 86.9 89.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 1154 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OH A 1155 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1156 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1157 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1158 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1160 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1161 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AZI RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) RECOMBINANT WILD-TYPE COMPLEXED WITH AZIDE REMARK 900 RELATED ID: 1BJE RELATED DB: PDB REMARK 900 H64T VARIANT OF MYOGLOBIN (HORSE HEART) RECOMBINANT WILD-TYPE REMARK 900 COMPLEXED WITH AZIDE REMARK 900 RELATED ID: 1DWR RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) WILD-TYPE COMPLEXED WITH CO REMARK 900 RELATED ID: 1DWS RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) WILD-TYPE COMPLEXED WITH CO REMARK 900 RELATED ID: 1DWT RELATED DB: PDB REMARK 900 PHOTORELAXED HORSE HEART MYOGLOBIN CO COMPLEX REMARK 900 RELATED ID: 1GJN RELATED DB: PDB REMARK 900 HYDROGEN PEROXIDE DERIVED MYOGLOBIN COMPOUND II AT PH 5.2 REMARK 900 RELATED ID: 1HRM RELATED DB: PDB REMARK 900 MYOGLOBIN MUTANT WITH HIS 93 REPLACED BY TYR (H93Y) REMARK 900 RELATED ID: 1HSY RELATED DB: PDB REMARK 900 MYOGLOBIN MUTANT WITH HIS 64 REPLACED BY THR (H64T) REMARK 900 RELATED ID: 1NPF RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) WILD-TYPE COMPLEXED WITH NITRICOXIDE REMARK 900 RELATED ID: 1NPG RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) WILD-TYPE COMPLEXED WITHNITROSOETHANE REMARK 900 RELATED ID: 1NZ2 RELATED DB: PDB REMARK 900 K45E VARIANT OF HORSE HEART MYOGLOBIN REMARK 900 RELATED ID: 1NZ3 RELATED DB: PDB REMARK 900 K45E-K63E VARIANT OF HORSE HEART MYOGLOBIN REMARK 900 RELATED ID: 1NZ4 RELATED DB: PDB REMARK 900 THE HORSE HEART MYOGLOBIN VARIANT K45E/K63E COMPLEXED WITHCADMIUM REMARK 900 RELATED ID: 1NZ5 RELATED DB: PDB REMARK 900 THE HORSE HEART MYOGLOBIN VARIANT K45E/K63E COMPLEXED WITHMANGANESE REMARK 900 RELATED ID: 1RSE RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) MUTANT WITH SER 92 REPLACED BY ASP (S92D) REMARK 900 RELATED ID: 1WLA RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) RECOMBINANT WILD-TYPE REMARK 900 RELATED ID: 1XCH RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) MUTANT WITH LEU 104 REPLACED BY ASN (L104N) REMARK 900 RELATED ID: 1YMA RELATED DB: PDB REMARK 900 MYOGLOBIN (HORSE HEART) MUTANT WITH HIS 64 REPLACED BY TYR (H64Y) REMARK 900 RELATED ID: 1YMB RELATED DB: PDB REMARK 900 METMYOGLOBIN (HORSE HEART) REMARK 900 RELATED ID: 1YMC RELATED DB: PDB REMARK 900 CYANOMET-SULFMYOGLOBIN (HORSE HEART) REMARK 900 RELATED ID: 2FRF RELATED DB: PDB REMARK 900 HORSE HEART MYOGLOBIN, NITRITE ADDUCT, CRYSTAL SOAK REMARK 900 RELATED ID: 2FRI RELATED DB: PDB REMARK 900 HORSE HEART MYOGLOBIN, NITRITE ADDUCT, CO- CRYSTALLIZED REMARK 900 RELATED ID: 2FRJ RELATED DB: PDB REMARK 900 NITROSYL HORSE HEART MYOGLOBIN, NITRITE/ DITHIONITE METHOD REMARK 900 RELATED ID: 2FRK RELATED DB: PDB REMARK 900 NITROSYL HORSE HEART MYOGLOBIN, NITRIC OXIDE GAS METHOD REMARK 900 RELATED ID: 2IN4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYOGLOBIN WITH CHARGE NEUTRALIZED HEME,ZNDMB- REMARK 900 DME REMARK 900 RELATED ID: 2V1E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RADIATION-INDUCED MYOGLOBIN COMPOUND II - REMARK 900 INTERMEDIATE H AT PH 6.8 REMARK 900 RELATED ID: 2V1G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RADIATION-INDUCED MYOGLOBIN COMPOUND II - REMARK 900 INTERMEDIATE H AT PH 5.2 REMARK 900 RELATED ID: 2V1H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RADIATION-INDUCED METMYOGLOBIN - AQUA FERROUS REMARK 900 MYOGLOBIN AT PH 5.2 REMARK 900 RELATED ID: 2V1I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RADIATION-INDUCED METMYOGLOBIN - AQUA FERROUS REMARK 900 MYOGLOBIN AT PH 6.8 REMARK 900 RELATED ID: 2V1J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RADIATION-INDUCED METMYOGLOBIN - AQUA FERROUS REMARK 900 MYOGLOBIN AT PH 8.7 REMARK 900 RELATED ID: 2V1K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FERROUS DEOXYMYOGLOBIN AT PH 6.8 DBREF 2V1F A 1 153 UNP P68082 MYG_HORSE 2 154 SEQRES 1 A 153 GLY LEU SER ASP GLY GLU TRP GLN GLN VAL LEU ASN VAL SEQRES 2 A 153 TRP GLY LYS VAL GLU ALA ASP ILE ALA GLY HIS GLY GLN SEQRES 3 A 153 GLU VAL LEU ILE ARG LEU PHE THR GLY HIS PRO GLU THR SEQRES 4 A 153 LEU GLU LYS PHE ASP LYS PHE LYS HIS LEU LYS THR GLU SEQRES 5 A 153 ALA GLU MET LYS ALA SER GLU ASP LEU LYS LYS HIS GLY SEQRES 6 A 153 THR VAL VAL LEU THR ALA LEU GLY GLY ILE LEU LYS LYS SEQRES 7 A 153 LYS GLY HIS HIS GLU ALA GLU LEU LYS PRO LEU ALA GLN SEQRES 8 A 153 SER HIS ALA THR LYS HIS LYS ILE PRO ILE LYS TYR LEU SEQRES 9 A 153 GLU PHE ILE SER ASP ALA ILE ILE HIS VAL LEU HIS SER SEQRES 10 A 153 LYS HIS PRO GLY ASP PHE GLY ALA ASP ALA GLN GLY ALA SEQRES 11 A 153 MET THR LYS ALA LEU GLU LEU PHE ARG ASN ASP ILE ALA SEQRES 12 A 153 ALA LYS TYR LYS GLU LEU GLY PHE GLN GLY HET HEM A1154 47 HET OH A1155 1 HET SO4 A1156 5 HET SO4 A1157 5 HET GOL A1158 12 HET GOL A1159 6 HET GOL A1160 6 HET GOL A1161 6 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM OH HYDROXIDE ION HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN HEM HEME HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 OH H O 1- FORMUL 4 SO4 2(O4 S 2-) FORMUL 6 GOL 4(C3 H8 O3) FORMUL 10 HOH *214(H2 O) HELIX 1 1 SER A 3 ASP A 20 1 18 HELIX 2 2 ASP A 20 HIS A 36 1 17 HELIX 3 3 HIS A 36 GLU A 41 1 6 HELIX 4 4 LYS A 42 LYS A 47 5 6 HELIX 5 5 THR A 51 SER A 58 1 8 HELIX 6 6 SER A 58 LYS A 77 1 20 HELIX 7 7 HIS A 82 LYS A 96 1 15 HELIX 8 8 PRO A 100 HIS A 119 1 20 HELIX 9 9 GLY A 124 GLY A 150 1 27 LINK NE2 HIS A 93 FE HEM A1154 1555 1555 2.11 LINK FE HEM A1154 O OH A1155 1555 1555 1.87 SITE 1 AC1 26 ARG A 31 LYS A 42 PHE A 43 LYS A 45 SITE 2 AC1 26 HIS A 64 VAL A 67 VAL A 68 LEU A 89 SITE 3 AC1 26 SER A 92 HIS A 93 HIS A 97 ILE A 99 SITE 4 AC1 26 TYR A 103 LEU A 104 HIS A 113 HIS A 116 SITE 5 AC1 26 GLN A 128 PHE A 138 OH A1155 GOL A1158 SITE 6 AC1 26 HOH A2199 HOH A2200 HOH A2201 HOH A2202 SITE 7 AC1 26 HOH A2203 HOH A2208 SITE 1 AC2 3 HIS A 64 VAL A 68 HEM A1154 SITE 1 AC3 6 LYS A 50 THR A 51 GLU A 52 HOH A2083 SITE 2 AC3 6 HOH A2204 HOH A2205 SITE 1 AC4 3 GLY A 1 HOH A2206 HOH A2207 SITE 1 AC5 10 LYS A 45 LYS A 63 HIS A 64 HIS A 113 SITE 2 AC5 10 HIS A 116 SER A 117 HEM A1154 HOH A2099 SITE 3 AC5 10 HOH A2208 HOH A2209 SITE 1 AC6 5 SER A 3 ASP A 4 GLY A 5 HOH A2211 SITE 2 AC6 5 HOH A2212 SITE 1 AC7 4 ASP A 20 LYS A 118 HOH A2146 HOH A2213 SITE 1 AC8 7 LEU A 11 GLY A 15 GLU A 18 PRO A 37 SITE 2 AC8 7 LYS A 77 HOH A2034 HOH A2214 CRYST1 62.970 28.668 35.537 90.00 105.74 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015881 0.000000 0.004476 0.00000 SCALE2 0.000000 0.034882 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029236 0.00000